These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1940 related articles for article (PubMed ID: 30128616)

  • 1. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
    World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
    Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
    Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

  • 5. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
    Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
    J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI-based Radiomics approaches on predicting response to neoadjuvant chemoradiotherapy (nCRT) in patients with rectal cancer.
    Cheng Y; Luo Y; Hu Y; Zhang Z; Wang X; Yu Q; Liu G; Cui E; Yu T; Jiang X
    Abdom Radiol (NY); 2021 Nov; 46(11):5072-5085. PubMed ID: 34302510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
    Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.
    Li Z; Ma X; Shen F; Lu H; Xia Y; Lu J
    BMC Med Imaging; 2021 Feb; 21(1):30. PubMed ID: 33593304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.
    Zhang B; Tian J; Dong D; Gu D; Dong Y; Zhang L; Lian Z; Liu J; Luo X; Pei S; Mo X; Huang W; Ouyang F; Guo B; Liang L; Chen W; Liang C; Zhang S
    Clin Cancer Res; 2017 Aug; 23(15):4259-4269. PubMed ID: 28280088
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiomics signature as a new biomarker for preoperative prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Zhang Z; Jiang X; Zhang R; Yu T; Liu S; Luo Y
    Diagn Interv Radiol; 2021 May; 27(3):308-314. PubMed ID: 34003118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
    Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
    Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics Analysis of Multiparametric MRI for the Preoperative Prediction of Lymph Node Metastasis in Cervical Cancer.
    Hou L; Zhou W; Ren J; Du X; Xin L; Zhao X; Cui Y; Zhang R
    Front Oncol; 2020; 10():1393. PubMed ID: 32974143
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer.
    Cui Y; Yang W; Ren J; Li D; Du X; Zhang J; Yang X
    Radiother Oncol; 2021 Jan; 154():161-169. PubMed ID: 32976874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 16. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
    Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
    Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
    Zhao R; Wan L; Chen S; Peng W; Liu X; Wang S; Li L; Zhang H
    Acad Radiol; 2024 Apr; 31(4):1367-1377. PubMed ID: 37802671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer.
    Kim S; Han K; Seo N; Kim HJ; Kim MJ; Koom WS; Ahn JB; Lim JS
    Eur Radiol; 2018 Dec; 28(12):5231-5240. PubMed ID: 29858637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer.
    Zhou X; Yi Y; Liu Z; Cao W; Lai B; Sun K; Li L; Zhou Z; Feng Y; Tian J
    Ann Surg Oncol; 2019 Jun; 26(6):1676-1684. PubMed ID: 30887373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
    Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 97.